Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine
about
Salmonella enterica serovars Typhimurium and Typhi as model organisms: revealing paradigm of host-pathogen interactionsThe microbiota mediates pathogen clearance from the gut lumen after non-typhoidal Salmonella diarrheaA structural basis for the mechanism of aspartate-beta-semialdehyde dehydrogenase from Vibrio choleraePhoB activates Escherichia coli O157:H7 virulence factors in response to inorganic phosphate limitationMsbA transporter-dependent lipid A 1-dephosphorylation on the periplasmic surface of the inner membrane: topography of francisella novicida LpxE expressed in Escherichia coliThe aspartate-semialdehyde dehydrogenase of Edwardsiella ictaluri and its use as balanced-lethal system in fish vaccinologyEvaluation of YadC protein delivered by live attenuated Salmonella as a vaccine against plagueBiogenesis of Yersinia pestis PsaA in recombinant attenuated Salmonella Typhimurium vaccine (RASV) strainYersinia pestis with regulated delayed attenuation as a vaccine candidate to induce protective immunity against plague.Multiple effects of Escherichia coli Nissle 1917 on growth, biofilm formation, and inflammation cytokines profile of Clostridium perfringens type A strain CP4.Α1-giardin based live heterologous vaccine protects against Giardia lamblia infection in a murine modelConstruction of recombinant attenuated Salmonella enterica serovar typhimurium vaccine vector strains for safety in newborn and infant mice.Immunogenicity of a live recombinant Salmonella enterica serovar typhimurium vaccine expressing pspA in neonates and infant mice born from naive and immunized mothersInnate immunity mediated by MyD88 signal is not essential for induction of lipopolysaccharide-specific B cell responses but is indispensable for protection against Salmonella enterica serovar Typhimurium infection.Inhibition of tumor growth and metastasis by a combination of Escherichia coli-mediated cytolytic therapy and radiotherapySalmonella enterica serovar enteritidis ghosts carrying the Escherichia coli heat-labile enterotoxin B subunit are capable of inducing enhanced protective immune responses.MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen.Potential role for mucosally active vaccines against pneumococcal pneumoniaMultiple antigens of Yersinia pestis delivered by live recombinant attenuated Salmonella vaccine strains elicit protective immunity against plagueFine-tuning synthesis of Yersinia pestis LcrV from runaway-like replication balanced-lethal plasmid in a Salmonella enterica serovar typhimurium vaccine induces protection against a lethal Y. pestis challenge in micePhysiology, pathogenicity and immunogenicity of lon and/or cpxR deleted mutants of Salmonella Gallinarum as vaccine candidates for fowl typhoidLive recombinant Salmonella Typhi vaccines constructed to investigate the role of rpoS in eliciting immunity to a heterologous antigenImmune responses to recombinant pneumococcal PsaA antigen delivered by a live attenuated Salmonella vaccine.Evaluation of the humoral immune response in mice orally vaccinated with live recombinant attenuated Salmonella enterica delivering a secreted form of Yersinia pestis PsaA.Partially assembled K99 fimbriae are required for protection.Salmonella vaccine vectors displaying delayed antigen synthesis in vivo to enhance immunogenicity.Delivery of woodchuck hepatitis virus-like particle presented influenza M2e by recombinant attenuated Salmonella displaying a delayed lysis phenotype.Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.LcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.Development of Streptococcus pneumoniae Vaccines Using Live VectorsEvaluation of Psn, HmuR and a modified LcrV protein delivered to mice by live attenuated Salmonella as a vaccine against bubonic and pneumonic Yersinia pestis challengeImmunization with Salmonella enterica serovar Typhimurium-derived outer membrane vesicles delivering the pneumococcal protein PspA confers protection against challenge with Streptococcus pneumoniae.Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.Enhancement of immune responses by an attenuated Salmonella enterica serovar Typhimurium strain secreting an Escherichia coli heat-labile enterotoxin B subunit protein as an adjuvant for a live Salmonella vaccine candidate.Bacterial infectious disease control by vaccine development.Cross-protection against Salmonella Typhimurium infection conferred by a live attenuated Salmonella Enteritidis vaccine.Development of a biosafety enhanced and immunogenic Salmonella enteritidis ghost using an antibiotic resistance gene free plasmid carrying a bacteriophage lysis system.Salmonella synthesizing 1-dephosphorylated [corrected] lipopolysaccharide exhibits low endotoxic activity while retaining its immunogenicity.Multilayered genetic safeguards limit growth of microorganisms to defined environmentsContribution of a Streptococcus mutans antigen expressed by a Salmonella vector vaccine in dendritic cell activation
P2860
Q26996526-1E368477-B02A-4B07-9E67-A095073A6A42Q27313421-3D8F71F9-E4E5-414A-997E-35370A59D37FQ27640202-DE91D75F-88B0-4A74-98D1-F0FE1D5385DCQ28542075-4D45CE65-0622-4836-BD66-D20E8417406AQ30840136-6C51E7EE-E077-4FA8-9B47-F138E70352E9Q30994198-CFAAD3E4-3187-460B-A156-EE42BE83C244Q33637474-1B20539F-2A9F-44AC-A365-31A8C9A2EE32Q33638369-90690256-11CC-49B9-9B26-F04F8C5AC8D5Q33675781-8C6FF5FE-1FA9-45A2-B25C-22C6825B62BCQ33684740-CAD166B0-2882-483B-A8D2-9DFBBEE88731Q33710976-E6F7547A-FBE1-45D1-AB6E-4173EED4EC10Q33725162-7C7792DD-2C18-4049-B97A-069AB1B05EAEQ33725174-64229924-B918-49F2-AC62-4562BD6478E0Q33725490-7D69D7C6-AC64-42ED-847E-E5E8BE089D18Q33731187-D5976A1E-A69E-4C83-9CA8-63582679ECB8Q33743411-B62F6EBE-0154-4165-A43E-1894F9E33F24Q33776975-136C5F6D-B0F0-4DB5-A356-30666438CE35Q33792681-7E6BA25B-1378-4841-BA33-54927246D1CAQ33834427-CC695C65-EEAF-4E55-BE0C-1FAB7A8C799EQ33877252-16DB1228-E3D9-4059-8E0B-C0C2C95BFF3BQ33920959-B8FB21A7-C158-48A9-B8E5-07F3D376F9BEQ33921859-AF919448-C419-41C2-A900-FC2344872E03Q33963100-1998C5C3-5FF6-4E3F-BEF1-C90606623927Q34065115-FFC3CEE4-A30A-4C4A-B6F4-ACDE6ACB26A0Q34111838-06DAE7AC-70FA-4DAC-BB5E-BE371038C33AQ34119481-B411751C-9164-4063-A8B4-A06FFE71DA07Q34126717-307D05FA-330B-4F9C-AFC1-478D54DD9DBCQ34130172-0E9E0508-2316-4DFE-8AE5-A517E394921AQ34298699-AF3733F5-670F-48BB-BA98-FE09238FF54BQ34316015-513FC3DF-5EC1-439B-A952-461E1051B23BQ34457319-79F1C0D6-AE5F-41B1-A1DF-12B00C874C89Q34529570-D7D67771-5745-473A-8291-775FE5157930Q34529634-6D8A5721-3A74-4551-A1A9-B91DD3AF4CA8Q34738751-979AF091-3572-4E64-BBB7-810AE5977DE9Q34785982-8FC850C3-8EDE-41B9-9A87-0108F379C5E3Q34813377-0E3D8A83-8185-4DF3-BCD0-705B2C71A904Q35036179-55B9942D-CCFC-4242-BB58-F3E9BE9C5CEAQ35059006-6ED88004-AF0E-4749-9ACD-97E264687523Q35088968-3245F912-ADC5-4E44-BEFA-945A1BE06776Q35191847-EF7F1C1B-6758-49A2-A81D-D9A24F370B43
P2860
Immune responses to recombinant pneumococcal PspA antigen delivered by live attenuated Salmonella enterica serovar typhimurium vaccine
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@ast
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@en
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@nl
type
label
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@ast
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@en
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@nl
prefLabel
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@ast
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@en
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@nl
P2093
P2860
P1476
Immune responses to recombinan ...... ca serovar typhimurium vaccine
@en
P2093
Ho Young Kang
Jay Srinivasan
Roy Curtiss
P2860
P304
P356
10.1128/IAI.70.4.1739-1749.2002
P407
P577
2002-04-01T00:00:00Z